Edwards Lifesciences Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	880,685	890,629	909,821	781,824	899,785	1,658,132
Market Cap Growth	-4.10%	-2.11%	16.37%	-13.11%	-45.73%	46.56%
Enterprise Value	819,322	833,958	833,119	763,173	879,267	1,635,365
Last Close Price	1365.23	1562.05	1543.21	1286.75	1425.52	2511.00
PE Ratio	45.57	46.08	10.46	32.98	30.31	53.81
PS Ratio	8.06	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.73	4.79	4.34	6.88	7.94	13.86
P/TBV Ratio	6.57	6.65	6.20	9.06	10.59	18.62
P/FCF Ratio	36.64	37.06	150.61	71.94	47.38	57.51
P/OCF Ratio	30.67	31.01	80.51	51.63	37.87	46.70
EV/Sales Ratio	7.76	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	25.83	25.81	24.62	28.05	26.81	46.34
EV/EBIT Ratio	28.76	28.28	27.00	30.35	29.24	50.28
EV/FCF Ratio	34.09	34.70	137.92	70.23	46.30	56.73
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.39	0.39	0.42	0.42	0.40	0.39
Debt / FCF Ratio	0.53	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.34	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.97	-1.97	-2.02	-0.59	-0.31	-0.45
Net Debt / FCF Ratio	-2.64	-2.64	-11.32	-1.47	-0.54	-0.55
Asset Turnover	0.45	0.45	0.49	0.57	0.53	0.67
Inventory Turnover	1.21	1.21	1.12	1.10	0.90	1.63
Quick Ratio	2.83	2.83	3.13	2.06	1.87	2.07
Current Ratio	3.72	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	10.35%	10.35%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	7.65%	7.65%	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	19.58%	19.98%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	13.80%	13.80%	12.80%	18.20%	21.20%	21.20%
Earnings Yield	2.19%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	2.73%	2.70%	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	2.25%	2.25%	1.66%	2.37%	1.11%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.